Home › Blog › Why Back Surgery Backfires

Interesting article this week posted at MSNBC.com about a recent study of patients undergoing low back surgery. The study demonstrated that of those patients who opted for back surgery, only 26% went back to work compared to 67% of the patients who didn’t get surgery. There was also an increase in the use of pain medications after surgery. As we have always said, for a very few patients, low back surgery can be a Godsend. However, that’s only about 1-2 in 10 (IMHO) of the patients currently undergoing back surgery. The problem with conventional low back surgery is that it either cuts out parts of the disc or fuses together vertebral segments that were built to move. By taking out parts of the disc, the surgery weakens the disc and makes it more likely to fail. To understand this phenomenon, think of the low back disc like a bicycle tire. As illustrated above, the thick outer rubber tube can develop cracks and tears which let the inner tube bulge out (just like a disc bulge). Rather than fixing the cracked outer rubber part, our current surgical approach just lops off a piece of the outer rubber tube (the part pressing on a nerve), making the tire less durable and more likely to fail. Low back surgery does the same thing, no matter if it’s through a scalpel or a laser. In the case of the low back, the outer rubber tube is the disc annulus (outer part of the disc) and the inner tube is the nucleus pulposis (inner rubbery gel part). Is there a better way? We believe in using a low back surgery alternative by either injecting substances to help the disc area heal (like the Regenexx-PL-Disc procedure) or to help heal the cracks (like the Regenexx-C-Disc stem cell procedure). We’ve seen significant improvement in low back discs by simply injecting the patient’s own specially grown stem cells into these tears. The upshot? Looking at the bicycle example, it’s no wonder why back surgery backfires.

Learn More About Regenexx^® Procedures

Request a digital booklet and more information to learn about alternatives to orthopedic surgery and the Regenexx patient experience.

Your Email *

Include the weekly newsletter. It's free and you can unsubscribe at any time.

Submit

We do not sell, or share your information to third party vendors. By submitting the form you agree that you've read and consent to our Privacy Policy.

Chris Centeno, MD is a specialist in regenerative medicine and the new field of Interventional Orthopedics. Centeno pioneered orthopedic stem cell procedures in 2005 and is responsible for a large amount of the published research on stem cell use for orthopedic applications. View Profile